- Systems
- Consumables
- Point-of-Care Testing Devices
Middle East and Africa Hemostasis diagnostics Market size was valued at USD x million in 2023 and is poised to grow at a CAGR of x% from 2024 - 2030. report gives historical, current, and future market sizes (US$ Mn) based on product type, test type, technology, end-user, and region. This report studies the Middle East and Africa Hemostasis diagnostics Market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment hot spots) and market unmet needs (Product Opportunities).
Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers, and service providers engaged. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from the damaged blood vessel. During the hemostasis, blood changes from a liquid state to a gelatinous state. Hemostasis is maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects.
Middle East And Africa Hemostasis Diagnostics Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
X%
Largest Market
South Africa
Fastest Growing Market
N/A
Middle East and Africa Hemostasis Diagnostics Market Dynamics
Increase in the prevalence of hemophilia disease in Middle East and Africa region (according to World Federation of Hemophilia Global Survey 2010, approximately 1,886 hemophilia cases were observed in South Africa), adoption of newer technologies by Middle East countries, and expansion of business by the market players into Middle East and Africa region are anticipated to fuel the hemostasis diagnostics market over the forecast period. However high cost of advanced hemostasis products and regulations bottlenecks for the test approvals are expected to hamper the growth of hemostasis diagnostics market.
Middle East and Africa Hemostasis Diagnostics Market
South Africa dominates the market
South Africa, and rest of Middle East and Africa. South Africa hemostasis diagnostics market is growing due to increase in the prevalence of hemophilia disease, advances in healthcare infrastructure, and increase in per capita income are anticipated to propel the market. Moreover, expansion of business into MEA region by market players, and launching of newer products also expected to propel the growth of market over forecast years.
Latin America
Europe
Asia Pacific
Middle East
North America
Middle East And Africa Hemostasis Diagnostics Market Segmentation
By Product Type
By Test Type
- Fibrinogen Test
- Activated Clotting Time
- Platelet Function
- Prothrombin Time
- Heparin & Protamine Dose-Response Test For ACT
- Activated Partial Thromboplastin Time
- Anti-Factor Xa
- Other Coagulation Tests
By Technology
- Optical
- Mechanical
- Electrochemical
- Others
By End User
- Hospitals
- Clinics
- Diagnostic Centres
- Others (POC)
Frequently Asked Questions
2023 is the base year and 2030 is the forecast year.
The Middle East and Africa Hemostasis Diagnostics Market Report data: (Middle East and Africa (MEA) GCC Countries, South Africa, Rest of MEA)
The Middle East and Africa Hemostasis Diagnostics Market key players are: Hoffmann-La Roche Ltd. (Switzerland) Sysmex Corporation (Japan) Abbott Laboratories (U.S.) Nihon Kohden Corporation (Japan) Siemens Healthineers (Germany) Grifols S.A (Spain) Beckman Coulter, Inc. (U.S.)
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
| 1. Executive Summary |
| 2. Middle East And Africa Hemostasis Diagnostics Market Introduction |
| 2.1. Middle East And Africa Hemostasis Diagnostics Market - Taxonomy |
| 2.2. Middle East And Africa Hemostasis Diagnostics Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Test Type |
| 2.2.3.Technology |
| 2.2.4.End User |
| 2.2.5.Region |
| 3. Middle East And Africa Hemostasis Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Middle East And Africa Hemostasis Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Middle East And Africa Hemostasis Diagnostics Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Systems |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Consumables |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Point-of-Care Testing Devices |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Middle East And Africa Hemostasis Diagnostics Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Fibrinogen Test |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Activated Clotting Time |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Platelet Function |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Prothrombin Time |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Heparin & Protamine Dose-Response Test For ACT |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Activated Partial Thromboplastin Time |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Anti-Factor Xa |
| 6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Other Coagulation Tests |
| 6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 7. Middle East And Africa Hemostasis Diagnostics Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Optical |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Mechanical |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Electrochemical |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Middle East And Africa Hemostasis Diagnostics Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Clinics |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Diagnostic Centres |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others (POC) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Middle East And Africa Hemostasis Diagnostics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Middle East and Africa (MEA) |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. GCC Countries |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. South Africa |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Rest of MEA |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 10. Middle East and Africa (MEA) Middle East And Africa Hemostasis Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Systems |
| 10.1.2.Consumables |
| 10.1.3.Point-of-Care Testing Devices |
| 10.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Fibrinogen Test |
| 10.2.2.Activated Clotting Time |
| 10.2.3.Platelet Function |
| 10.2.4.Prothrombin Time |
| 10.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 10.2.6.Activated Partial Thromboplastin Time |
| 10.2.7.Anti-Factor Xa |
| 10.2.8.Other Coagulation Tests |
| 10.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Optical |
| 10.3.2.Mechanical |
| 10.3.3.Electrochemical |
| 10.3.4.Others |
| 10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Clinics |
| 10.4.3.Diagnostic Centres |
| 10.4.4.Others (POC) |
| 11. GCC Countries Middle East And Africa Hemostasis Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Systems |
| 11.1.2.Consumables |
| 11.1.3.Point-of-Care Testing Devices |
| 11.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Fibrinogen Test |
| 11.2.2.Activated Clotting Time |
| 11.2.3.Platelet Function |
| 11.2.4.Prothrombin Time |
| 11.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 11.2.6.Activated Partial Thromboplastin Time |
| 11.2.7.Anti-Factor Xa |
| 11.2.8.Other Coagulation Tests |
| 11.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Optical |
| 11.3.2.Mechanical |
| 11.3.3.Electrochemical |
| 11.3.4.Others |
| 11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Clinics |
| 11.4.3.Diagnostic Centres |
| 11.4.4.Others (POC) |
| 12. South Africa Middle East And Africa Hemostasis Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Systems |
| 12.1.2.Consumables |
| 12.1.3.Point-of-Care Testing Devices |
| 12.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Fibrinogen Test |
| 12.2.2.Activated Clotting Time |
| 12.2.3.Platelet Function |
| 12.2.4.Prothrombin Time |
| 12.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 12.2.6.Activated Partial Thromboplastin Time |
| 12.2.7.Anti-Factor Xa |
| 12.2.8.Other Coagulation Tests |
| 12.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Optical |
| 12.3.2.Mechanical |
| 12.3.3.Electrochemical |
| 12.3.4.Others |
| 12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Clinics |
| 12.4.3.Diagnostic Centres |
| 12.4.4.Others (POC) |
| 13. Rest of MEA Middle East And Africa Hemostasis Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Systems |
| 13.1.2.Consumables |
| 13.1.3.Point-of-Care Testing Devices |
| 13.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Fibrinogen Test |
| 13.2.2.Activated Clotting Time |
| 13.2.3.Platelet Function |
| 13.2.4.Prothrombin Time |
| 13.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 13.2.6.Activated Partial Thromboplastin Time |
| 13.2.7.Anti-Factor Xa |
| 13.2.8.Other Coagulation Tests |
| 13.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Optical |
| 13.3.2.Mechanical |
| 13.3.3.Electrochemical |
| 13.3.4.Others |
| 13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Clinics |
| 13.4.3.Diagnostic Centres |
| 13.4.4.Others (POC) |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Hoffmann-La Roche Ltd. (Switzerland) |
| 14.2.2.Sysmex Corporation (Japan) |
| 14.2.3.Abbott Laboratories (U.S.) |
| 14.2.4.Nihon Kohden Corporation (Japan) |
| 14.2.5.Siemens Healthineers (Germany) |
| 14.2.6.Grifols S.A (Spain) |
| 14.2.7.Beckman Coulter, Inc. (U.S.) |
| 14. Research Methodology |
| 16. Appendix and Abbreviations |
- Hoffmann-La Roche Ltd. (Switzerland)
- Sysmex Corporation (Japan)
- Abbott Laboratories (U.S.)
- Nihon Kohden Corporation (Japan)
- Siemens Healthineers (Germany)
- Grifols S.A (Spain)
- Beckman Coulter, Inc. (U.S.)